Skip to main content
. 2023 Jun 24;75:101762. doi: 10.1016/j.molmet.2023.101762

Table 3.

Summary of plasma pharmacokinetic parameters for ecnoglutide at steady state (MAD Day 36).

Ecnoglutide dose group
Parameter 0.2 mg (N = 8) 0.4 mg (N = 8) 0.6 mg (N = 7)
Cmax,ss (ng/mL)
n 7 8 6
Mean 25.3286 46.6875 84.7333
SD
3.4913
7.0786
10.9237
Tmax,ss (hr)
n 7 8 6
Median 72.000 39.042 12.000

AUC0-inf,ss (hr∗ng/mL)
n 6 8 5
Mean 6611.5447 11658.1612 21604.9215
SD
1017.6543
2654.8702
4555.4539
t1/2,ss (hr)
n 7 8 6
Mean 124.1109 138.0929 128.6007
SD
16.5586
23.0285
13.5973
CL/F,ss (L/hr)
n 6 8 5
Mean 0.0575 0.0669 0.0533
SD
0.0092
0.0108
0.0095
Vz/F,ss (L)
n 6 8 5
Mean 10.6958 13.2773 10.1639
SD
2.1566
2.9711
1.6094
RAAUC/D
n 7 8 5
Mean 1.8102 1.9709 2.2325
SD
0.2241
0.2409
0.2413
RACmax/D n 7 8 6
Mean 1.7192 1.9248 2.1125
SD 0.2426 0.3312 0.2546

Abbreviations: AUC = area under plasma time–concentration curve; Cmax = maximum plasma concentration; CL/F = apparent total body clearance; RA = accumulation ratio; SD = Standard Deviation; SS = steady state; Tmax = time to reach the maximum plasma concentration; t½ = elimination half-life. Vz/F = apparent volume of distribution.